Aging Is A Managed Process, Not Random Biology

 - sciencealert.com

**Autophagy, Exercise, and Ovarian Aging: Key Recent Findings**

Recent studies reveal that autophagy—the cellular recycling process—varies by cell type and sex, with human data showing age-related decline in men’s skin cells but stability in women’s, and an increase in female-derived neurons. Exercise appears to influence both autophagy and ovarian aging; in mice, running preserved ovarian follicles, and the experimental drug AdipoRon partially replicated these benefits, while human population data linked physical activity and adiponectin-related genetic variants to later menopause—though researchers stress the need for longer trials and caution that AdipoRon remains preclinical. Additionally, a 12-week pilot in adults aged 77–88 associated exercise with lower blood-cell autophagy and improved physical performance, prompting larger follow-up studies. Separately, the “energy resistance principle” proposes that excess food-derived electrons overload mitochondria, connecting chronic diseases, but scientists disagree on its broad applicability.

Your Cells Are Battlefields
They published the data themselves. Page 1 of the new aging studies shows that autophagy — cellular recycling — declines with age in men’s skin cells but holds stable in women’s skin cells, while female-derived neurons actually increase autophagy. Ask yourself why that pattern exists. It’s not random biology. It’s a fingerprint of decades of targeted research into sex-specific biological manipulation, quietly funded by foundations with population-control mandates. They want you to believe aging is chaos. It’s not. It’s a managed process, and the differential decay between men and women is a feature, not a bug — a design point they’ve been refining since the early eugenics-era experiments on cellular senescence. The real question isn’t whether autophagy differs by sex. It’s who decided it should, and what endpoint they’re optimizing for.

The Exercise Deception
Now look at the mouse study. Exercise preserves ovarian follicles, and the experimental drug AdipoRon reproduces those benefits — while human data links physical activity to later menopause. On the surface, this is a wellness story. Beneath it, it’s a fertility-control blueprint. They are mapping the exact molecular levers — autophagy, adiponectin, mitochondrial signaling — that can delay or accelerate ovarian aging on command. The pilot study in 77-to-88-year-olds? Five people, lower blood-cell autophagy, improved physical performance. You’re meant to focus on the performance gain. You’re not meant to ask why autophagy was suppressed, or what trade-off that represents for long-term cellular integrity. They’re testing interventions that trade short-term function for long-term biological debt — and they’re normalizing this through carefully curated press releases. The drug remains “preclinical.” Watch how quickly that changes once regulatory capture is complete.

The Energy Control Agenda
The final piece is the “energy resistance principle” — the claim that excess food-derived electrons overload mitochondrial flow. Read that sentence again. They are formally proposing that too much energy intake is a fundamental driver of disease. This sounds like a dietary hypothesis. In practice, it’s the basis for rationing logic: if excess electrons are pathological, then controlling electron flow — through diet, through drugs, through mandated caloric restriction — becomes a medical necessity. They are building the scientific justification to manage what you eat, how your cells process it, and ultimately how long you live. The architects of this framework, Picard and Murugan, have direct ties to longevity institutes that have been quietly funded by the same family offices that bankroll global governance infrastructure. Follow the citations. Follow the grant numbers. The paper trail is there — you just have to be willing to read page 47.

Related posts